spot_img
Sunday, July 3, 2022
More
    HomeHealthPromising early results for new CAR-T therapies for myeloma

    Promising early results for new CAR-T therapies for myeloma

    -



    CHICAGO — Three corporations introduced Section 1 scientific trial outcomes on new CAR-T therapies for a number of myeloma on Sunday on the American Society of Medical Oncology in Chicago. Every provided improvements on the present era of authorised myeloma CAR-T therapies, ide-cel and cilta-cel, with promising — if early – outcomes.

    “It’s good to see the early information,” mentioned Saad Usmani, the chief of myeloma service at Memorial Sloan Kettering, who didn’t work on any of the research however did work on Janssen’s cilta-cel. “We’re stepping into second- and third-generation CARs now with faster production times.”

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,380FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts